Susan Flint

Ms. Flint brings more than 30 years of experience across the pharmaceutical industry, covering the US, EU and Canada; with a focus on drug development, clinical operations, and regulatory affairs. She has experience in project management and quality procedures for clinical research. Ms. Flint has managed more than 75 clinical studies, including over 20 Phase 3 clinical trials.

She has led clinical operations at increasing levels of responsibility in companies such as Wilson Therapeutics AB, filing over 20 INDs and over 10 NDAs/MAAs throughout her career. Her expertise ranges from pre-IND to commercial stage drug development, with a focus in neurological, rare, and orphan diseases, and she has filed over 15 510(k)s, 3 PMAs, and 4 ODAs.

Ms. Flint received her Bachelor of Science in Biology at Bridgewater State College and her Master of Sciences in Pharmacology at Northeastern University.